Cancer Discov. 2017 Apr;7(4):OF2. doi: 10.1158/2159-8290.CD-NB2017-030. Epub 2017 Mar 1.
A multidisciplinary panel of experts has issued guidelines that consolidate current evidence on testing for molecular biomarkers in colorectal cancer. The guidelines aim to standardize molecular testing for patients with colorectal cancer and help clinicians identify patients most likely to benefit from targeted treatments.
一个多学科专家小组发布了指南,整合了目前关于结直肠癌分子生物标志物检测的证据。这些指南旨在为结直肠癌患者的分子检测标准化,并帮助临床医生确定最有可能从靶向治疗中获益的患者。